{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:10:43Z","timestamp":1759407043633,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020622","name":"Translational Health Science and Technology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T03:50:48Z","timestamp":1696823448000},"page":"1051-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety, immunogenicity and efficacy of Relcovax\u00ae, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5768-9554","authenticated-orcid":false,"given":"Nikhil","family":"Sathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0492-9705","authenticated-orcid":false,"given":"Leena","family":"Parte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjaneyulu","family":"Gadiparthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6253-8850","authenticated-orcid":false,"given":"Satish","family":"Kad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayandev","family":"Sensarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4679-2175","authenticated-orcid":false,"given":"Hassan","family":"Nalband","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sangapillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sivashanmuganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhi","family":"Pusalkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathyavathy","family":"Anandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Masand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Pratapreddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Harinarayana Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-1921","authenticated-orcid":false,"given":"Abhiram","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.E.C.","family":"Vidyadhar Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopala","family":"Karanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-1157","authenticated-orcid":false,"given":"Abhishek","family":"Phatarphekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Ramana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.10.006_b0005","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.10.006_b0010","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.10.006_b0015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2023.10.006_b0020","unstructured":"https:\/\/covid19.who.int\/."},{"key":"10.1016\/j.vaccine.2023.10.006_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.10.006_b0030","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2023.10.006_b0035","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.1128\/JVI.00647-20","article-title":"The nucleocapsid protein of SARS-CoV-2: a target for vaccine development","volume":"94","author":"Dutta","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.10.006_b0040","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.vaccine.2023.10.006_b0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.006_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41541-021-00321-8","article-title":"Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters","volume":"6","author":"Jia","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.006_b0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2100421","article-title":"Cutting edge: Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity","volume":"207","author":"Matchett","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.10.006_b0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2016.12.019","article-title":"NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants","volume":"517","author":"Art","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2023.10.006_b0065","doi-asserted-by":"crossref","unstructured":"Gupta RK, Rost BE. Aluminum Compounds as Vaccine Adjuvants. In: O'Hagan DT, editor. Vaccine Adjuvants, Methods in Molecular Medicine, Totowa NJ: Springer; 2000, p. 65-89. Doi: 10.1385\/1-59259-083-7:65.","DOI":"10.1385\/1-59259-083-7:65"},{"key":"10.1016\/j.vaccine.2023.10.006_b0070","series-title":"Vaccine Adjuvants, Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-6445-1_2","article-title":"Development of the CpG Adjuvant 1018: A Case Study","author":"Campbell","year":"2017"},{"issue":"32","key":"10.1016\/j.vaccine.2023.10.006_b0075","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1016\/j.vaccine.2022.06.026","article-title":"Relcovax\u00ae, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice","volume":"40","author":"Phatarphekar","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.006_b0080","unstructured":"OECD, 1998a. OECD Principles of Good Laboratory Practice (As Revised in 1997). In: OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. Organisation for Economic Co-Operation & Development (OECD), Environment Directorate, Chemicals Group and Management Committee, OECD Environmental Health and Safety Publications, Paris, France. No. 1, ENV\/MC\/CHEM(98)17. https:\/\/www.oecd.org\/officialdocuments\/publicdisplaydocumentpdf\/?cote=env\/mc\/chem(98)17&doclanguage=en."},{"key":"10.1016\/j.vaccine.2023.10.006_b0085","doi-asserted-by":"crossref","unstructured":"OECD, 1998b. Repeated dose 90-day oral toxicity study in rodents. In: OECD Guidelines for the Testing of Chemicals. Organisation for Economic Co-operation and Development (OECD), Paris, France. OECD Guideline no 408 [Updated & Adopted 21st September 1998]. Doi: 10.1787\/20745788.","DOI":"10.1787\/20745788"},{"key":"10.1016\/j.vaccine.2023.10.006_b0090","unstructured":"Compendium of Control, and Supervision of Experiments on Animals (CPCSEA), 2018. Ministry of Environment, Forest and Climate Change Government of India. http:\/\/cpcsea.nic.in\/WriteReadData\/userfiles\/file\/Compendium%20of%20CPCSEA.pdf."},{"issue":"9","key":"10.1016\/j.vaccine.2023.10.006_b0095","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.10.006_b0100","doi-asserted-by":"crossref","first-page":"e73522","DOI":"10.7554\/eLife.73522","article-title":"Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection","volume":"11","author":"Rizvi","year":"2022","journal-title":"Elife"},{"issue":"7818","key":"10.1016\/j.vaccine.2023.10.006_b0105","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.006_b0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.clpt.6100243","article-title":"Preclinical predictors of clinical safety: opportunities for improvement","volume":"82","author":"Sistare","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2023.10.006_b0115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/eji.200636800","article-title":"Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion","volume":"37","author":"Katsenelson","year":"2007","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.006_b0120","doi-asserted-by":"crossref","first-page":"00076","DOI":"10.15406\/ijvv.2017.04.00076","article-title":"Short review of aluminum hydroxide related lesions in preclinical studies and their relevance","volume":"4","author":"Warfving","year":"2017","journal-title":"Int J Vaccines Vaccin"},{"issue":"3","key":"10.1016\/j.vaccine.2023.10.006_b0125","first-page":"149","article-title":"SARS-CoV-2 receptor-binding mutations and antibody contact sites","volume":"4","author":"Mejdani","year":"2021","journal-title":"Antib Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2023.10.006_b0130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.it.2020.09.004","article-title":"Structural basis of SARS-CoV-2 and SARS-CoV antibody interactions","volume":"41","author":"Gavor","year":"2020","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.006_b0135","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.006_b0140","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41392-021-00861-4","article-title":"Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2023.10.006_b0145","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3390\/vaccines10122080","article-title":"Preclinical toxicity and immunogenicity of a COVID-19 vaccine (ZF2001) in cynomolgus monkeys","volume":"10","author":"Yang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.10.006_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111980","article-title":"Interleukin-17A (IL-17A): A silent amplifier of COVID-19","volume":"142","author":"Maione","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.vaccine.2023.10.006_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103213","article-title":"The role of Interleukin-4 in COVID-19 associated male infertility - A hypothesis","volume":"142","author":"Renu","year":"2020","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2023.10.006_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198171","article-title":"IFN-\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection","volume":"289","author":"Gadotti","year":"2020","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:33:05Z","timestamp":1759404785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23011763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X23011763"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, immunogenicity and efficacy of Relcovax\u00ae, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}